Archibal, Kayesha Khate .
HRN: 23-88-66 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2023
CEFUROXIME 750MG (VIAL)
10/12/2023
10/18/2023
IVT
750mg
Q8hrs
Uti
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes